Joris Pezzini is a Biopharma executive with 15 years of experience in the Healthcare industry, gained through science and business roles in start-up, mid-size pharma, and consulting firms.
Before joining Alira Health in 2019, Joris led business development activities for UCB, a €4B pharma company focusing on neurology, immunology, and bone diseases.
Prior to UCB, Joris served as Executive Vice President of Strategy and Business Development at LFB, a €500M, 2000 employee Biopharma developing Immunology products through four proprietary platforms (plasma derivatives, transgenic animals, cell culture, and cell therapy).
Before LFB, Joris spent three years at Bionest Partners as a strategy consultant in healthcare. He began his career as a scientist in California and the UK specializing in the production of monoclonal antibodies.
Joris is a Biotechnology engineer and holds a Business and Leadership degree from Harvard Business School.